Actelis Networks (NASDAQ:ASNS) Announces Earnings Results
Actelis Networks (NASDAQ:ASNS – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.24), Zacks reports. Actelis Networks had a negative net margin of 56.82% and a negative return on equity of 752.62%. The business had revenue of $3.00 […]
SurgePays (NASDAQ:SURG) Announces Quarterly Earnings Results, Misses Estimates By $0.62 EPS
SurgePays (NASDAQ:SURG – Get Free Report) issued its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.62), Zacks reports. SurgePays had a negative net margin of 27.39% and a negative return on equity of 55.63%. SurgePays Stock Performance Shares of SURG […]
Camden National Co. (NASDAQ:CAC) Announces Quarterly Dividend of $0.42
Camden National Co. (NASDAQ:CAC – Get Free Report) declared a quarterly dividend on Tuesday, March 25th, RTT News reports. Stockholders of record on Tuesday, April 15th will be paid a dividend of 0.42 per share by the financial services provider on Wednesday, April 30th. This represents a $1.68 annualized dividend and a dividend yield of […]
CarParts.com (NASDAQ:PRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS
CarParts.com (NASDAQ:PRTS – Get Free Report) issued its quarterly earnings results on Tuesday. The specialty retailer reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.08), Zacks reports. CarParts.com had a negative net margin of 5.11% and a negative return on equity of 29.57%. CarParts.com Price Performance PRTS traded […]
Aprea Therapeutics (NASDAQ:APRE) Releases Earnings Results, Beats Estimates By $0.20 EPS
Aprea Therapeutics (NASDAQ:APRE – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.49) EPS for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.20, Zacks reports. Aprea Therapeutics had a negative return on equity of 57.86% and a negative net margin of 1,029.50%. Aprea Therapeutics Stock Performance Shares of […]
last updated on 26 Mar 08:45